TLX
Telix Pharmaceuticals LtdCompany with tickers: TLX, TLPPF
CIK
2007191
CUSIP
87961M105
Shares Outstanding
338,777,049
13F Activity (30d)
30 filings
28 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-11 | Jellison William R |
Director | Other | 0 |
| 2026-05-11 | GILL DAVID N |
Director | Other | 0 |
| 2026-05-11 | Rivas Maria |
Director | Other | 0 |
| 2026-04-29 | Behrenbruch Christian |
Director, MD & Group CEO | Buy | 33,435 |
| 2026-04-28 | Behrenbruch Christian |
Director, MD & Group CEO | Buy | 34,500 |
| 2026-03-29 | Smith Darren Charlton |
Group Chief Financial Officer | Convert | 1,111 |
| 2026-03-29 | Smith Darren Charlton |
Group Chief Financial Officer | Convert | 1,111 |
| 2026-03-18 | Cade David Norman |
Group Chief Medical Officer | Other | 0 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 0 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 0 |
| 2026-03-18 | Cade David Norman |
Group Chief Medical Officer | Other | 0 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 0 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 804 |
| 2026-03-18 | Skinner Jann Elizabeth |
Director | Other | 595,000 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 25,558 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 254,006 |
| 2026-03-18 | Cade David Norman |
Group Chief Medical Officer | Other | 373,133 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 0 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 0 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 0 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 0 |
| 2026-03-18 | Cade David Norman |
Group Chief Medical Officer | Other | 0 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 0 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 10,810 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 0 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 0 |
| 2026-03-18 | Cade David Norman |
Group Chief Medical Officer | Other | 0 |
| 2026-03-18 | McDonald Marie Elizabeth |
Director | Other | 3,719 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 0 |
| 2026-03-18 | Nelson Mark Alexander |
Director | Other | 3,628,750 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 20,675,000 |
| 2026-03-18 | Behrenbruch Christian |
Director, MD & Group CEO | Other | 400,000 |
| 2026-03-18 | Patti Darren Joel |
Group Chief Operating Officer | Other | 0 |
| 2026-03-18 | Smith Darren Charlton |
Group Chief Financial Officer | Other | 0 |
Showing 1–34 of 34 transactions